Imiglucerase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Imiglucerase. Educational only — not medical advice.
Labeled uses
CEREZYME is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients.
Source: FDA labeling via NIH DailyMed (set df60f030…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.